244 related articles for article (PubMed ID: 24767765)
1. Impact of high-dose statin pre-treatment and contrast-induced acute kidney injury on follow-up events in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
Patti G; Leoncini M; Toso A; Maioli M; Grieco D; Colonna G; Bellandi F; Di Sciascio G
Int J Cardiol; 2014 Jun; 174(2):440-1. PubMed ID: 24767765
[No Abstract] [Full Text] [Related]
2. Early high-dose rosuvastatin and cardioprotection in the protective effect of rosuvastatin and antiplatelet therapy on contrast-induced acute kidney injury and myocardial damage in patients with acute coronary syndrome (PRATO-ACS) study.
Leoncini M; Toso A; Maioli M; Tropeano F; Badia T; Villani S; Bellandi F
Am Heart J; 2014 Nov; 168(5):792-7. PubMed ID: 25440809
[TBL] [Abstract][Full Text] [Related]
3. Meta-analysis of short-term high versus low doses of atorvastatin preventing contrast-induced acute kidney injury in patients undergoing coronary angiography/percutaneous coronary intervention.
Wu H; Li D; Fang M; Han H; Wang H
J Clin Pharmacol; 2015 Feb; 55(2):123-31. PubMed ID: 25310898
[TBL] [Abstract][Full Text] [Related]
4. Relationship between inflammation and benefits of early high-dose rosuvastatin on contrast-induced nephropathy in patients with acute coronary syndrome: the pathophysiological link in the PRATO-ACS study (Protective Effect of Rosuvastatin and Antiplatelet Therapy on Contrast-Induced Nephropathy and Myocardial Damage in Patients With Acute Coronary Syndrome Undergoing Coronary Intervention).
Toso A; Leoncini M; Maioli M; Tropeano F; Di Vincenzo E; Villani S; Bellandi F
JACC Cardiovasc Interv; 2014 Dec; 7(12):1421-9. PubMed ID: 25523533
[TBL] [Abstract][Full Text] [Related]
5. [The Saturn study].
Fineschi M; Gaspardone A
G Ital Cardiol (Rome); 2012; 13(7-8):469-73. PubMed ID: 22781373
[No Abstract] [Full Text] [Related]
6. Early high-dose rosuvastatin for contrast-induced nephropathy prevention in acute coronary syndrome: Results from the PRATO-ACS Study (Protective Effect of Rosuvastatin and Antiplatelet Therapy On contrast-induced acute kidney injury and myocardial damage in patients with Acute Coronary Syndrome).
Leoncini M; Toso A; Maioli M; Tropeano F; Villani S; Bellandi F
J Am Coll Cardiol; 2014 Jan 7-14; 63(1):71-9. PubMed ID: 24076283
[TBL] [Abstract][Full Text] [Related]
7. The effects and mechanisms of high loading dose rosuvastatin therapy before percutaneous coronary intervention in patients with acute coronary syndrome.
Luo J; Li J; Shen X; Hu X; Fang Z; Lv X; Zhou S
Int J Cardiol; 2013 Sep; 167(5):2350-3. PubMed ID: 23194788
[No Abstract] [Full Text] [Related]
8. Importance of intensive lipid lowering in acute coronary syndrome and percutaneous coronary intervention.
Kumar A; Cannon CP
J Interv Cardiol; 2007 Dec; 20(6):447-57. PubMed ID: 18042049
[TBL] [Abstract][Full Text] [Related]
9. Current statin usage for patients with acute coronary syndrome undergoing percutaneous coronary intervention: multicenter survey in Korea.
Kim MJ; Jeon DS; Gwon HC; Kim SJ; Chang K; Kim HS; Tahk SJ;
Clin Cardiol; 2012 Nov; 35(11):700-6. PubMed ID: 22825844
[TBL] [Abstract][Full Text] [Related]
10. Rosuvastatin versus atorvastatin to prevent contrast induced nephropathy in patients undergoing primary percutaneous coronary intervention (ROSA-cIN trial).
Kaya A; Kurt M; Tanboğa IH; Işik T; Ekinci M; Aksakal E; Kaya Y; Topçu S; Sevimli S
Acta Cardiol; 2013 Oct; 68(5):489-94. PubMed ID: 24283110
[TBL] [Abstract][Full Text] [Related]
11. Comparison of high reloading ROsuvastatin and Atorvastatin pretreatment in patients undergoing elective PCI to reduce the incidence of MyocArdial periprocedural necrosis. The ROMA II trial.
Sardella G; Lucisano L; Mancone M; Conti G; Calcagno S; Stio RE; Pennacchi M; Biondi-Zoccai G; Canali E; Fedele F
Int J Cardiol; 2013 Oct; 168(4):3715-20. PubMed ID: 23849964
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the efficacy of rosuvastatin versus atorvastatin in reducing apolipoprotein B/apolipoprotein A-1 ratio in patients with acute coronary syndrome: results of the CENTAURUS study.
Lablanche JM; Leone A; Merkely B; Morais J; Alonso J; Santini M; Eha J; Demil N; Licour M; Tardif JC;
Arch Cardiovasc Dis; 2010 Mar; 103(3):160-9. PubMed ID: 20417447
[TBL] [Abstract][Full Text] [Related]
13. Effects of rosuvastatin and atorvastatin on the apolipoprotein B/apolipoprotein A-1 ratio in patients with an acute coronary syndrome: The CENTAURUS trial design.
Lablanche JM; Danchin N; Farnier M; Tedgui A; Vicaut E; Alonso J; Crean P; Leone A; Morais J; Santini M; Licour M; Farah M; Tardif JC
Arch Cardiovasc Dis; 2008 Jun; 101(6):399-406. PubMed ID: 18809153
[TBL] [Abstract][Full Text] [Related]
14. [The PRATO-ACS study].
Marenzi G; Briguori C
G Ital Cardiol (Rome); 2013 Dec; 14(12):803-8. PubMed ID: 24336595
[No Abstract] [Full Text] [Related]
15. Comparison of lipid-modifying efficacy of rosuvastatin versus atorvastatin in patients with acute coronary syndrome (from the LUNAR study).
Pitt B; Loscalzo J; Monyak J; Miller E; Raichlen J
Am J Cardiol; 2012 May; 109(9):1239-46. PubMed ID: 22360820
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the efficacy of rosuvastatin versus atorvastatin in preventing contrast induced nephropathy in patient with chronic kidney disease undergoing percutaneous coronary intervention.
Liu Y; Liu YH; Tan N; Chen JY; Zhou YL; Li LW; Duan CY; Chen PY; Luo JF; Li HL; Wei-Guo
PLoS One; 2014; 9(10):e111124. PubMed ID: 25357250
[TBL] [Abstract][Full Text] [Related]
17. First head-to-head study comparing rosuvastatin and atorvastatin effects on the treatment of atherosclerosis.
Cardiovasc J Afr; 2008; 19(1):60. PubMed ID: 18320096
[No Abstract] [Full Text] [Related]
18. Statin wars: emphasis on potency vs event reduction and safety?
Lavie CJ; Milani RV; O'Keefe JH
Mayo Clin Proc; 2007 May; 82(5):539-42. PubMed ID: 17493417
[No Abstract] [Full Text] [Related]
19. Temporal trends in the use of high-dose potent statins following acute coronary syndrome in Israel.
Elis A; Pereg D; Dicker D; Gevrielov-Yusim N; Goldenberg I; Matetzky S; Kopel E; Klempfner R
Cardiology; 2014; 128(3):266-72. PubMed ID: 24863615
[TBL] [Abstract][Full Text] [Related]
20. High coronary plaque load: a heavy burden.
de Graaf MA; Jukema JW
Eur Heart J; 2013 Nov; 34(41):3168-70. PubMed ID: 23966308
[No Abstract] [Full Text] [Related]
[Next] [New Search]
